vaccines

News

CureVac claims advantage in BioNTech patent dispute

A court in Germany has suspended a trial discussing litigation brought against BioNTech and Pfizer by CureVac alleging patent infringement in connection with their mRNA-ba

News

US researchers start trials of universal flu vaccine

Researchers at the National Institutes of Health (NIH) have started dosing patients in a phase 1 trial of a new influenza vaccine candidate that aims to sidestep the annua

News

FDA clears new Pfizer, Moderna COVID jabs as cases tick up

The FDA has authorised updated versions of Pfizer/BioNTech and Moderna's mRNA-based COVID-19 vaccines targeting the XBB.1.5 subvariant, in time for the start of a new autu

News

Moderna, Pfizer say COVID jabs work against BA.2.86

Moderna and Pfizer have both said that updated versions of their COVID-19 vaccines work against the highly mutated BA.2.86 variant, also known as Pirola, which is being cl

News

UK opens '100-day' rapid-response vaccine unit

The UK government has formally opened a state-of-the-art vaccine research facility based at the UK Health and Security Agency (UKHSA) to improve the country's preparedness

News

Merck's challenge to Pfizer's Prevnar grows

Pfizer's longstanding dominance of the pneumococcal vaccines category could be threatened by Merck & Co, which has just reported new data on its V116 shot in older adu

CureVac claims advantage in BioNTech patent dispute

US researchers start trials of universal flu vaccine

FDA clears new Pfizer, Moderna COVID jabs as cases tick up

Moderna, Pfizer say COVID jabs work against BA.2.86

UK opens '100-day' rapid-response vaccine unit

Merck's challenge to Pfizer's Prevnar grows

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

vaccines

Editor's Picks